
Viewpoint: A shot in the arm for generics producers
Domino inksThere is nowhere to hide from the Falsified Medicines Directive. It impacts generics producers in the same way as any other drug manufacturer or re-packager selling into Europe. With just under 48 months to go before the deadline, which is likely to be mid-2018, the clock is ticking for all producers to get their house in order.
The subject was hot on the agenda at the European Generics Association (EGA) meeting in Madrid earlier this month. As generics manufacturers often supply products with much lower margins than patented drug producers, their budgets are restricted when it comes to new investment – which is why many of them have been holding out until the last minute to find the ‘best-fit’ solution for their businesses.
Related Posts
Alfano praises anti-counterfeiting police raid in Naples
Interior Minister Angelino Alfano on Wednesday praised an operation in which...
60 per cent water, juice in Kenya is counterfeit – KRA
More of the water and juice on the Kenyan market is counterfeit, KRA has said,...
Over one kg gold seized, international passenger and receiver arrested in Chennai
Chennai: Air Intelligence Unit (AIU) officials at the Chennai International...
After 14-yr slumber, DCGI wakes up to side effects of ‘wonder drug’
Fourteen years after giving it the go ahead, the Drug Controller General of India...